glp-1 drugs competitive intelligence 2025

glp-1 drugs competitive intelligence 2025 Unpacking $100B+ Obesity Market Opportunity: What It Means for Biopharma, Payers, and Providers GLP-1 Receptor Agonist Market Size

Name: glp-1 drugs competitive intelligence 2025 Unpacking $100B+ Obesity Market Opportunity: What It Means for Biopharma, Payers, and Providers GLP-1 Receptor Agonist Market Size
Brand: aeroscroll.com
SKU: 60065475911
Price: 21.43 USD
Availability: InStock
Rating: 4.2691 (24 reviews)

SKU: 60065475911

4.3

USD21.43 USD69.43

Pay in 4 interest-free payments of $5.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

[DOI] [PubMed] [PMC] Fetissov SO, Dchelotte P

(MP4 3429 kb) Studies investigating the mechanism of action of GLP-1RA therapy for causing weight loss provide evidence that GLP-1RA treatment is associated with reductions in appetite and hunger, lower preference for energy-dense foods, alteration in food reward pathways, decrease in food cravings, and improvement in eating control (Table 2) [25, 26, 33, 34]